You are here

  • Home
  • Archive
  • Volume 12, Issue 4
  • Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer

Article metrics

Article menu

Download PDFPDF

Immune cell therapies and immune cell engineering
Original research
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer

 

Online download statistics by month:

Online download statistics by month: April 2024 to January 2026

AbstractFullPdf
Apr 2024726730211
May 2024261263148
Jun 202417618095
Jul 2024195198244
Aug 202410910782
Sep 2024163165350
Oct 2024145145221
Nov 2024185187105
Dec 202416716996
Jan 202515815979
Feb 2025248248107
Mar 202515615795
Apr 2025211210125
May 2025134136105
Jun 2025878778
Jul 2025110
Aug 2025110
Jan 2026100
Total312431432141